Cardinal HealthvsMerck & Company

CAH and MRK stock compared: price, dividend, valuation and results, from SEC filings.

CAH

Cardinal Health, Inc.

$279.62

Value $65.0B

+0.13%
CAH's page

MRK

Merck & Company, Inc.

$139.53

Value $345B

-2.68%
MRK's page

Cardinal Health (CAH) has a market value of $65.0B and Merck & Company (MRK) $345B. Over the last year, with dividends, CAH moved +36.9% and MRK +54.7%. The P/E is 35.8 for CAH and 140.6 for MRK. Dividend yield: CAH 0.73%, MRK 2.44%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CAH$65.0B

    MRK$345B

    MRK is 5.3 times CAH

  • Revenue, 12 months

    CAH$258B

    MRK$67.4B

    CAH is 3.8 times MRK

  • Net income, 12 months

    CAH$1.8B

    MRK$2.5B

    MRK is 1.3 times CAH

  • Operating margin

    CAH1.1%

    MRK–

  • ROIC

    CAH35.7%

    MRK3.9%

    31.8 points apart

  • P/E

    CAH35.8

    MRK140.6

    MRK is 3.9 times CAH

  • Dividend yield

    CAH0.7%

    MRK2.4%

    1.7 points apart

  • 5-year return

    CAH+522.5%

    MRK+96.8%

    425.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CAH+522.5%

MRK+96.8%

20040060020222023202420252026
Returns by period
PeriodCAHWith dividendsMRKWith dividends
1 year since November 17, 2025+36.9%Price +35.6%+54.7%Price +50.3%
3 years since November 17, 2023+182.3%+41.3% a yearPrice +170.5%+50.3%+14.5% a yearPrice +37.1%
5 years since November 17, 2021+522.5%+44.2% a yearPrice +462.3%+96.8%+14.5% a yearPrice +68.9%
10 years since November 18, 2016+420.0%+17.9% a yearPrice +295.1%+220.7%+12.4% a yearPrice +136.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CAHCardinal HealthMRKMerck & Company

Valuation

CAHMRK
Valuation
Price$279.62$139.53
Market value$65.0B$345B
Enterprise value (EV)$68.6B$389B
P/E35.8140.6
P/E, 5-year median30.714.8
P/B–7.7
EV/EBIT25.481.7
Free cash flow yield7.5%4.3%

Results and growth

CAHMRK
Results and growth
Revenue, 12 months$258B$67.4B
Net income, 12 months$1.8B$2.5B
Free cash flow, 12 months$4.9B$14.7B
Earnings per share, 12 months$7.82$0.98
Revenue growth, year on year14.2%1.3%
Revenue growth a year, past+9.4%over 5 years+9.4%over 5 years
EPS growth a year, past+28.3%over 5 years+21.2%over 5 years

Margins and returns on capital

CAHMRK
Margins and returns on capital
Gross margin3.9%71.8%
Operating margin1.1%–
Net margin0.7%3.6%
ROIC35.7%3.9%
ROE–5.2%

Balance sheet

CAHMRK
Balance sheet
Cash$5.3B$9.7B
Total debt$8.8B$53.8B
Net debt / EBITDA1.05.7
Interest cover7.9×2.4×

Dividends and buybacks

CAHMRK
Dividends and buybacks
Dividend yield0.7%2.4%
Dividend per share, 12 months$2.05$3.40
Dividend growth a year, past+1.0%over 5 years+5.8%over 5 years
Buyback yield2.1%1.5%
Shareholder yield2.8%3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CAH or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Cardinal Health or Merck & Company?

By market value, Merck & Company ($345B) is about 5.3 times Cardinal Health ($65.0B), at today's prices.

How did CAH and MRK stock do over the last 10 years?

Since November 18, 2016, CAH's price moved +295.1% and MRK's +136.3%. With dividends: CAH +420.0% (+17.9% a year), MRK +220.7% (+12.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, CAH or MRK?

The dividend yield at today's price is 0.73% for Cardinal Health and 2.44% for Merck & Company. Over the last twelve months they paid $2.05 and $3.40 per share.

What is the P/E of CAH and MRK?

At today's price, the P/E is 35.8 for CAH and 140.6 for MRK. The median of the last five years was 30.7 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Cardinal Health or Merck & Company?

Over the last twelve months, the net margin was 0.7% for Cardinal Health and 3.6% for Merck & Company, and the operating margin 1.1% and –. Revenue was $258B and $67.4B.

Which is the better investment, Cardinal Health or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.